VEGENICS PTY LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 13242
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 10157
 
  
 
C07K PEPTIDES 9127
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 1239
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1139
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1106

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9896499 Growth factor antagonists for organ transplant alloimmunity and arteriosclerosisApr 15, 15Feb 20, 18[A61K, C12N, C07K]
9745558 VEGFR-3 ligand binding molecules and uses thereofFeb 13, 14Aug 29, 17[A61K, C12N, C07K]
9260526 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapyNov 17, 14Feb 16, 16[C07H, A61K, C12N, C07K]
9073997 Growth factor antagonists for organ transplant alloimmunity and arteriosclerosisFeb 01, 08Jul 07, 15[A61K, C07K]
8940695 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapyJan 06, 06Jan 27, 15[A61K, C12N, C07K]
8759286 Pharmaceutical compositions comprising a VEGF-D polypeptideApr 19, 13Jun 24, 14[A61K, C07K]
8444957 Methods of screening for neoplastic disease statesFeb 17, 10May 21, 13[A61K, G01N]
8025886 Modified VEGF-A with improved angiogenic propertiesAug 15, 06Sep 27, 11[A61K, C07H, C12P, A61F, C12N, A61B, C07K]
7871798 Mammalian cells that express VEGF-D polypeptidesAug 23, 07Jan 18, 11[C07H, C12N]
7829091 Therapy targeting FLT4 (VEGER-3) expressed in blood vesselsFeb 09, 04Nov 09, 10[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0224,191 Combination Treatment with VEGF-C AntagonistsAbandonedApr 27, 15Aug 13, 15[A61K]
2014/0072,511 FLT4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPYAbandonedApr 18, 13Mar 13, 14[A61K]
8637262 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereofExpiredOct 05, 12Jan 28, 14[G01N, C07K]
2013/0344,065 Combination Treatment with VEGF-C AntagonistsAbandonedAug 29, 13Dec 26, 13[A61K]
8461109 Method of enhancing the acceptance and/or healing of a skin graftExpiredApr 17, 12Jun 11, 13[A61K, C07K]
8455453 Use of VEGF-D gene to prevent restenosisExpiredFeb 24, 05Jun 04, 13[A61K, C12N]
2013/0089,551 TREATMENT OF PULMONARY EDEMAAbandonedOct 05, 12Apr 11, 13[A61K]
8383788 C-Fos induced growth factor (FIGF) and DNA encoding sameExpiredMay 07, 02Feb 26, 13[C07H, A61K, C12N, C07K]
2013/0039,930 BIOMARKER FOR SENSITIVITY TO THERAPY WITH A NOTCH INHIBITORAbandonedJun 08, 12Feb 14, 13[A61K, C12Q, G01N, G06F, A61P]
8357669 Method of treatment for lymphedema comprising administering a polynucleotide encoding VEGF-DExpiredSep 23, 11Jan 22, 13[A61K]
8282931 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereofExpiredSep 10, 10Oct 09, 12[A61K, C07K]
8278098 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteinsExpiredJan 28, 11Oct 02, 12[C12N]
2012/0207,671 COMBINATION TREATMENT WITH VEGF-C ANTAGONISTSAbandonedApr 05, 11Aug 16, 12[A61K, A61P]
8227410 Methods of stimulating wound healing by administration of vascular endothelial growth factor D (VEGF-D)ExpiredMar 16, 11Jul 24, 12[A61K, C07K]
2012/0141,424 Materials and Methods for the Treatment of HypertensionAbandonedJan 07, 10Jun 07, 12[A61K, A61P]
2012/0093,811 ANTI-VEGF-D ANTIBODIESAbandonedApr 01, 10Apr 19, 12[A61K, C12N, A61P, C07K]
2012/0071,406 MODIFIED VEGF-A WITH IMPROVED ANGIOGENIC PROPERTIESAbandonedAug 19, 11Mar 22, 12[A61K, C07H, C12N, A61P, C07K]
2011/0305,703 ISOLATED VEGF-C AND VEGF-D PEPTIDES AND USES THEREOFAbandonedDec 08, 09Dec 15, 11[A61K, C12N, G01N, A61P, C40B, C07K]
2011/0142,839 TREATMENT OF PULMONARY EDEMAAbandonedMay 29, 09Jun 16, 11[A61K, A61P]
7928061 Methods of using VEGF-D polypeptidesExpiredOct 30, 07Apr 19, 11[A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.